Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity

Ilkow, Carolina S, Marguerie, Monique, Batenchuk, Cory, Mayer, Justin, Ben Neriah, Daniela, Cousineau, Sophie, Falls, Theresa, Jennings, Victoria A +22 more·2015·Nature Medicine
DOI 10.1038/nm.3848

Cited by (165)

Items 101–165 of 165

  1. Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts
    Jitao Wu, Cuicui Yu, Li Cai, Youyi Lu, Lei Jiang, Chu Liu, Yongwei Li, Fan Feng, Zhenli Gao, Zhe Zhu et al. · 2017 · Oncotarget
  2. In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses
    Yuqi Jing, Valery A. Chavez, Natasha Karishma Khatwani, Yuguang J. Ban, Andrea P. Espejo Freire, Xi Chen, Jaime Rafael Merchan · 2020 · Cancer Gene Therapy
  3. A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer
    Jiao Chen, Daphne Weihs, Fred J. Vermolen · 2020 · Bulletin of Mathematical Biology
  4. Deciphering permissivity of human tumor ecosystems to oncolytic viruses
    Benjamin Schoeps, Ulrich M. Lauer, Knut Elbers · 2025 · Oncogene
  5. Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference
    Donald J. Bastin, Amelia Sadie Aitken, Adrian Pelin, Larissa A. Pikor, Mathieu J. F. Crupi, Michael S. Huh, Marie‐Claude Bourgeois‐Daigneault, John Cameron Bell, Carolina S. Ilkow · 2018 · Journal for ImmunoTherapy of Cancer
  6. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer
    Giti Esmail Nia, Elahe Nikpayam, Molood Farrokhi, Azam Bolhassani, Ralph Leo Johan Meuwissen · 2024 · Molecular Therapy Oncology
  7. Tuning cellular metabolism for cancer virotherapy
    Dian Xiong, Qing Wang, Weiming Wang, Zhi‐Jun Sun · 2024 · Cancer Letters
  8. Research progress and development potential of oncolytic vaccinia virus
    Xinyu Zhang, Jiangshan He, Yiming Shao · 2025 · Chinese Medical Journal
  9. Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
    Donald J. Bastin, Scott R. Walsh, Meena Al Saigh, Yonghong Wan · 2016 · Biomedicines
  10. Oncolytic Viruses as Nanomedicines against the Tumor Microenvironment
    Uzma Zaheer, Neeraja A. Hassain, Banu, Shabeena, Shilu Mathew · 2021 · Biointerface Research in Applied Chemistry
  11. Oncolytic virus-induced IL-1β + monocyte-IL-6 + CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer
    Fan Li, Jingru Chen, Yuanke Li, Wei Wang, Yi Yang, Jie Wang, Minghui Han, Han Wang, Feilong Zhou, Wenxuan Ma et al. · 2025 · Journal for ImmunoTherapy of Cancer
  12. Lidocaine Modulates Cytokine Production and Reprograms the Tumor Immune Microenvironment to Enhance Anti-Tumor Immune Responses in Gastric Cancer
    Yi-Ying Wu, Ming-Shan Chen, I‐Chun Chen, Feng‐Hsu Wu, Tsai‐Ling Liao, Hsiao‐Wei Wen, Brent L. Nielsen, Hung‐Jen Liu · 2025 · International Journal of Molecular Sciences
  13. Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer
    Carmen M. Wong, Kathy L. Poulin, Grace Tong, Carin Christou, Michael A. Kennedy, Theresa J. Falls, John Cameron Bell, Robin J. Parks · 2016 · PLoS ONE
  14. Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer Metastasis
    Mohamed Hammad, Yvonne R. Cornejo, Linda Flores, Caitlyn Hyde, Hoi Wa Ngai, Min Li, Thanh Hue Dellinger, Jianming Lü, Nanhai G. Chen, Rachael Mooney et al. · 2020 · Molecular Therapy — Oncolytics
  15. Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?
    Sara Shayan, Arash Arashkia, Kayhan Azadmanesh · 2022 · Cancer Cell International
  16. Transarterial viroembolization improves the therapeutic efficacy of immune-excluded liver cancer: Three birds with one stone
    Yanyan Cao, Fu Xiong, Xuefeng Kan, Xiaopeng Guo, Tao Ouyang, Runyang Wang, Junhan Yang, Linkang Cai, Binlei Liu, Bin Liang et al. · 2022 · Pharmacological Research
  17. All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy
    Derek R. Clements, Youra Kim, Shashi Ashok Gujar, Patrick WK Lee · 2015 · OncoImmunology
  18. Murine Tumor Models for Oncolytic Rhabdo-Virotherapy
    Theresa J. Falls, Dominic Guy Roy, John Cameron Bell, Marie‐Claude Bourgeois‐Daigneault · 2016 · ILAR Journal
  19. Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
    Lingling Gao, Xiao Li, Qian Guo, Xin Nie, Yingying Hao, Qing Lin Liu, Juanjuan Liu, Liancheng Zhu, Limei Yan, Bei Lin · 2020 · Cancer Cell International
  20. Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
    Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, Farzan Siddiqui, Shyam Nyati · 2024 · International Journal of Molecular Sciences
  21. The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response
    Ibrahem Al-Obaidi, Ciaran Sandhu, Bilal Javaid Qureshi, Leonard William Seymour · 2024 · Heliyon
  22. Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation
    Christoph F. Kollmann, Nadine van Montfoort, Pierre Cordelier, Jonathan G. Pol, David P. Olagnier · 2025 · Seminars in Immunology
  23. Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment
    Victoria A. Jennings, Reah Rumbold-Hall, Gemma Migneco, Tyler Barr, Katrina Reilly, Nicola Ingram, Isabelle St Hilare, Samuel Heaton, Noura Alzamel, David Jackson et al. · 2024 · Frontiers in Immunology
  24. Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future
    Lorraine Quillien, Louis Buscail, Pierre Cordelier · 2022 · Human Gene Therapy
  25. Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells
    Matthew Holmes, Gina B. Scott, Samuel Heaton, Tyler Barr, Basem Askar, Louise M. E. Müller, Victoria A. Jennings, Christy Ralph, Cathy Burton, Alan A. Melcher et al. · 2023 · Molecular Therapy — Oncolytics
  26. Strategies and challenges in promoting chimeric antigen receptor T cells trafficking and infiltration of solid tumors
    Shibo Wang, Xinyu Du, Zhao Shen, Yongzhan Nie · 2025 · Chinese Medical Journal
  27. Reovirus oncolysis and the next frontiers for this unique oncoviral immunotherapy
    Negar Sharifi, Amir Darb Emamie, Nastaran Rafiee, Salar Pashangzadeh, Eknoor Walia, Nikolas Tim Martin, Huy‐Dung Hoang, Xiao Xiang, Tommy Alain · 2025 · Seminars in Immunology
  28. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis
    Zirui Jia, Jiacheng Gao, Yuhang Wang, Tingting Zhou, Xiangwen Zhang, Guo Zu · 2022 · Scientific Reports
  29. Oncolytic immunotherapy: The new clinical outbreak
    Jean‐François Fonteneau, Carole Achard, Cécile Zaupa, Johann Foloppe, Philippe Erbs · 2015 · OncoImmunology
  30. Cross-Talk Between Tumor Cells and Stellate Cells Promotes Oncolytic VSV Activity in Intrahepatic Cholangiocarcinoma
    Victoria Neumeyer, Purva Chavan, Katja Steiger, Oliver Ebert, Jennifer Altomonte · 2025 · Cancers
  31. Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma
    Yuping Derek Li, David A. Giles, Yi Huang, Ashwani Kesarwani, Tong Hu, Logan Page, Amanda De Andrade Costa, Jingqin Rosy Luo, Alexandra A. Wolfarth, Donghoon Choi et al. · 2026 · Nature Communications
  32. Systematic analysis of expression profiles and prognostic significance of the FGF gene family in pancreatic adenocarcinoma
    Yuxin Chen, Xiaojuan Liu, Ling Yang, Jia-Jing He, Yongmei Jiang, Jia Mai · 2022 · Oncology Letters
  33. A framework for the rational design of oncolytic viruses: A holistic perspective considering the tumour microenvironment
    Dylan Thomas, Priya Rose Bharadwa, Timothy T. Lee, Carolina S. Ilkow · 2025 · Seminars in Immunology
  34. Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy
    Shiqun Wang, Jiwu Wei · 2022 · International Journal of Cancer
  35. Immunological Assessment of Recent Immunotherapy for Colorectal Cancer
    Subhadeep Das, Diptikanta Acharya · 2023 · Immunological Investigations
  36. Unveiling the nexus: Oncolytic viruses, extracellular vesicles, and immune modulation
    Pierre Cordelier · 2025 · Molecular Therapy Oncology
  37. Viral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges
    Jean‐Simon Diallo · 2019 · Elsevier eBooks
  38. Infectious Optimism following the 10th International Oncolytic Virus Meeting
    Matthew J. Atherton, Laura Evgin, Brian A. Keller, Mira M. Shenouda, Kyle B. Stephenson, Richard G. Vile, John Cameron Bell, David H. Evans, Brian Dennis Lichty · 2017 · Molecular Therapy — Oncolytics
  39. Molecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)
    Lilia Antonova, Piriya Paramanthan, Theresa J. Falls, Marie-Ève Wedge, Justin Mayer, Harman S. Sekhon, John Peter McPherson, Robert Edward Denroche, Steve Gallinger, John Cameron Bell et al. · 2024 · Cancers
  40. Personalized virotherapy in cancer
    Eduardo G. A. Cafferata, Osvaldo Luis Podhajcer · 2015 · Aging
  41. Enhancing oncolytic virotherapy by exosome-mediated microRNA reprograming of the tumour microenvironment
    Victoria A. Jennings, Reah Rumbold-Hall, Gemma Migneco, Tyler Barr, Katarina Reilly, Nicola Ingram, Isabelle St Hilare, Samuel Heaton, Noura Alzamel, David Jackson et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Neospora caninum Inhibits Lewis Cancer and B16f10 Melanoma Lung Metastasis Development by Activating the Immune Response in Murine Models
    Weifeng Qian, Yaqi Chen, Chen Li, Xiaojin Li, Chaochao Lv, Yanyan Jia, Suhui Hu, Min Zhang, Tianqi Wang, Wenchao Yan et al. · 2025 · Acta Parasitologica
  43. Exploring the inherent susceptibility of cancer-associated fibroblasts to oncolytic virus infection
    Nicole Dam, Gavriil Ioannidis, Lukas J.A.C. Hawinkels, Vera Kemp · 2026 · Expert Opinion on Biological Therapy
  44. Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8+ T cells
    Lingkai Kong, Kua Liu, Yan Liu, Huawei Cui, Peng Wang, Jiannan Qiu, Qilei Xin, Dan Zhou, Wencui Liu, Fangkun Zhao et al. · 2026 · Communications Medicine
  45. Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8+ T cell immunity via rewiring MHC-I antigen presentation
    Huolun Feng, Yuhan Zhang, Zuda Huang, Jianlong Zhou, Yongfeng Liu, Xiao Xiao, Mingxi Chen, Xin Wen Guo, Jiabin Zheng, Zejian Lyu et al. · 2026 · Cell Reports Medicine
  46. A Transnational Study of Vocational Guidance and Counselling Provision for Women Returners.
    Pamela Clayton · 1996 · Adults learning
  47. Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors
    Siddhi Nath Paudel, Brian J. Hutzen, Katherine E. Miller, Elizabeth A.R. Garfinkle, Chun‐Yu Chen, Pin-Yi Wang, Andrea M. Glaspell, Mark A. Currier, Emily M. Ringwalt, Louis Boon et al. · 2024 · Frontiers in Immunology
  48. A cross-talk network that facilitates tumor virotherapy
    Agnieszka Bronisz, Ennio Antonio Chiocca · 2015 · Nature Medicine
  49. Oncolytic Virus Therapy for the Treatment of Metastatic Ovarian Cancer
    Jessica Tong · 2016 · Scholarship@Western (Western University)
  50. REOVIRUS-DRIVEN MYELOID CELLS IN ONCOLYTIC VIRUS THERAPY AND INFECTION
    Derek R. Clements · 2018 · DalSpace (Dalhousie University)
  51. Faculty Opinions recommendation of Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies.
    Jay A. Berzofsky · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  52. Clinicopathological and prognostic value of Lysyl oxidase expression in gastric cancer: a meta-analysis and bioinformatics analysis
    Zirui Jia, Jiacheng Gao, Yuhang Wang, Tingting Zhou, Zhang Xiangwen, Guo Zu · 2022 · Research Square
  53. Genetically modified virus for oral squamous cell carcinoma therapeutics
    Pitchiah Sivaperumal, T. Pavithra, Kannan Kamala · 2024 · Oral Oncology Reports
  54. The Role of CD4+ T Cells in Oncolytic Virotherapy
    Jui‐Ling Yu, Hsiu‐Chuan Wei, Sophia R.‐J. Jang · 2025 · Mathematical Methods in the Applied Sciences
  55. ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts to reovirus
    Nicole Dam, Tom J. Harryvan, Hao Dang, Gavriil Ioannidis, Bernhard Schmierer, Lukas J.A.C. Hawinkels, Vera Kemp · 2025 · Molecular Therapy Oncology
  56. The role of non-cancer cell infections in oncolytic virus therapy
    Jahanara Rajwani, Douglas J. Mahoney · 2025 · Seminars in Immunology
  57. Additional file 1 of Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
    Li, Ming, Li, Guoping, Kiyokawa, Juri, Zain A. Tirmizi, Leland G. Richardson, Ning, Jianfang, Das, Saumya, Martuza, Robert L., Stemmer-Rachamimov, Anat, Samuel D. Rabkin et al. · 2020 · Figshare
  58. Additional file 1 of Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
    Gao, Lingling, Li, Xiao, Qian Guo, Xin Nie, Yingying Hao, Liu, Qing, Liu, Juanjuan, Zhu, Liancheng, Yan, Limei, Lin, Bei · 2020 · Figshare
  59. Ciblage pharmacologique du microenvironnement de l'adénocarcinome canalaire pancréatique
    Rémi Samain · 2018
  60. Characterisation of SG33 Myxoma virus replication and oncolytic activity in pancreatic cancer models
    Lorraine Quillien · 2021
  61. Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy
    Mélissa Viens, Karen Geoffroy, Elline Meuriot, Alexandra Buccilli, Victor Mullins‐Dansereau, Marie-Lou Myre, Stamatios Paradisis, Angelina Bardoul, Emma Mary Kalin, Bruna Araripe Saraiva et al. · 2026 · Molecular Therapy
  62. Oncolytic measles virus reprograms the tumor microenvironment in a vascularized mesothelioma-on-chip model
    Nikita Rajkumari, Mégane Willems, Judith Fresquet, Elise Douillard, Magali Devic, Frédéric Tangy, Hortense Perdrieau, Delphine Fradin, Jean‐François Fonteneau, Nicolas Boisgerault et al. · 2026 · Research Square
  63. Oncolytic Viruses: A Paradigm Shift in Cancer Treatment
    Amama Rani, Bonglee Kim · 2026 · Springer eBooks
  64. Therapeutic targeting of cancer-associated fibroblasts with oncolytic virus in preclinical models of intrahepatic cholangiocarcinoma
    Aushinie M. Abeynayake, Timothy A. Rengers, Danielle Marie Carlson, Amro M. Abdelrahman, Justin W. Maroun, Nidhi Jalan‐Sakrikar, Velia Penza, Shruthi Naik, Mark Joseph Truty, Caitlin B. Conboy et al. · 2026 · Molecular Therapy Oncology
  65. Research progress in intratumoral microbiota: unlocking the potential of cancer immunotherapy
    Tian Tian, Min Chen · 2026 · Frontiers in Immunology